nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Phase II Trial of Gemcitabine/Carboplatin with or Without Trastuzumab in the First-Line Treatment of Patients with Metastatic Breast Cancer
|
Yardley, Denise A. |
|
2008 |
8 |
5 |
p. 425-431 7 p. |
artikel |
2 |
Carboplatin plus Gemcitabine Repeating Doublet Therapy in Recurrent Breast Cancer
|
Nagourney, Robert A. |
|
2008 |
8 |
5 |
p. 432-435 4 p. |
artikel |
3 |
Cardiac Morbidity and Mortality After Breast Conservation Treatment in Patients with Early-Stage Breast Cancer and Preexisting Cardiac Disease
|
Gutt, Ruchika |
|
2008 |
8 |
5 |
p. 443-448 6 p. |
artikel |
4 |
Erratum
|
|
|
2008 |
8 |
5 |
p. 457- 1 p. |
artikel |
5 |
Evolution of Bevacizumab-Based Therapy in the Management of Breast Cancer
|
Sachdev, Jasgit C. |
|
2008 |
8 |
5 |
p. 402-410 9 p. |
artikel |
6 |
Extended Adjuvant Endocrine Therapy in Breast Cancer: Current Status and Future Directions
|
Goss, Paul E. |
|
2008 |
8 |
5 |
p. 411-417 7 p. |
artikel |
7 |
Immunomodulatory Therapy in Multiple Sclerosis and Breast Cancer Risk: A Case Report and Literature Review
|
Amaria, Rodabe N. |
|
2008 |
8 |
5 |
p. 449-452 4 p. |
artikel |
8 |
Multicentric, Randomized Phase III Trial of Two Different Adjuvant Chemotherapy Regimens plus Three Versus Twelve Months of Trastuzumab in Patients with HER2-Positive Breast Cancer (Short-HER Trial; NCT00629278)
|
Guarneri, Valentina |
|
2008 |
8 |
5 |
p. 453-456 4 p. |
artikel |
9 |
Prolonged Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel in Breast Cancer Is Feasible
|
Dang, Chau |
|
2008 |
8 |
5 |
p. 418-424 7 p. |
artikel |
10 |
Retrospective Evaluation of Clinical Outcomes in Patients with HER2-Positive Advanced Breast Cancer Progressing on Trastuzumab-Based Therapy in the Pre-Lapatinib Era
|
Montemurro, Filippo |
|
2008 |
8 |
5 |
p. 436-442 7 p. |
artikel |
11 |
Unraveling the Biologic and Clinical Complexities of HER2
|
Park, John W. |
|
2008 |
8 |
5 |
p. 392-401 10 p. |
artikel |